Research reveals potential target for alcohol liver disease

August 21, 2017, Beth Israel Deaconess Medical Center

Drinking too much alcohol can damage the liver, but investigators have discovered a protective response in the organ that might be targeted to help treat alcoholic liver disease. The team—led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with colleagues at the University of Pennsylvania—also found that the same protective response may be involved in aversion to alcohol and could therefore help in the treatment of alcoholism.

The research involves a protein called fibroblast growth factor 21 (FGF21), which the scientists previously found helps protect mice against diet-related toxicities to the liver. "Looking at the relationship between -induced liver disease and FGF21 was the next step," said co-senior author Eleftheria Maratos-Flier, MD, Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism at BIDMC and Harvard Medical School.

In this latest work, published online today in Molecular Metabolism, people who binged on alcohol over a one-hour period exhibited massive increases of FGF21 in their blood six hours later. Similar results were seen in mice. Also, in mice bred to lack FGF21, binging on alcohol led to more liver damage than that seen in wild-type mice, along with an increased expression of genes involved in inflammation and scarring in the liver.

"We showed that alcohol consumption induces FGF21 as a in the liver that reduces the degree of alcohol-induced damage," said Maratos-Flier. "Because humans and mice have similar responses, mice may be a good model for studying this further."

Interestingly, alcohol was cleared normally in mice lacking FGF21, suggesting that FGF21 does not play a role in acute alcohol metabolism. Also, mice that were bred to overexpress FGF21 consumed less alcohol than wild-type mice. A similar effect was observed when wild-type mice were administered extra FGF21, which caused them to prefer water over alcohol.

The findings suggest that FGF21 has a dual role in alcohol metabolism. Acutely, the rise in FGF21 in response to inhibits further drinking. Chronically, the rise in FGF21 expression in the liver may protect against liver damage.

"Our results may encourage the development of drugs that mimic FGF21 for the treatment of , and possibly to produce alcohol aversion," Maratos-Flier noted.

The next steps in this line of research include tests on whether boosting the effects of FGF21 can help limit or reverse in and decrease a preference for alcohol in humans.

Explore further: Liver hormone reduces preference for sweets, alcohol, via brain's reward pathway

Related Stories

Liver hormone reduces preference for sweets, alcohol, via brain's reward pathway

December 24, 2015
A liver hormone works via the brain's reward pathway to reduce cravings for sweets and alcohol in mammals, UT Southwestern Medical Center researchers have found.

Protein may improve liver regeneration

March 31, 2015
Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα ...

Tweaking muscle metabolism prevents obesity and diabetes in mice

June 28, 2017
Mildly stressing muscle metabolism boosts levels of a beneficial hormone that prevents obesity and diabetes in mice, according to a new study by researchers at the University of Iowa.

Life-extending hormone bolsters the body's immune function

January 11, 2016
A hormone that extends lifespan in mice by 40% is produced by specialized cells in the thymus gland, according to a new study by Yale School of Medicine researchers. The team also found that increasing the levels of this ...

Study identifies liver-generated hormone that regulates 'sweet tooth'

December 24, 2015
We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible.

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.